US Stock MarketDetailed Quotes

LPTX Leap Therapeutics

Watchlist

2.5500
-0.0300-1.16%

Close Nov 22 16:00 ET

2.6300
+0.0800+3.14%

Post 18:10 ET

97.71MMarket Cap-1554P/E (TTM)

Leap Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Leap Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Leap Therapeutics Earnings Reports

Leap Therapeutics | 8-K: Leap Therapeutics Reports Third Quarter 2024 Financial Results

Nov 13 07:13 ET

Leap Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13 06:52 ET

Leap Therapeutics | 8-K: Leap Therapeutics Reports Second Quarter 2024 Financial Results

Aug 12 07:15 ET

Leap Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12 06:56 ET

Analyst Rating

Updated: Nov 15, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall